JPS60126252A - ４・４’−ジエトオキシブチルアミンの脂肪族カルボン酸塩およびその製造方法 - Google Patents

４・４’−ジエトオキシブチルアミンの脂肪族カルボン酸塩およびその製造方法

Info

Publication number: JPS60126252A
Authority: JP; Japan
Prior art keywords: formula; preparation; aliphatic carboxylate; diethoxybutylammonium; shedoxybutylamine
Prior art date: 1983-12-13
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

JP58235622A

Other languages

English (en)

Japanese (ja)

Other versions

JPS632949B2 (da

Inventor

Yukio Yanagimoto

行雄柳本

Yoshio Fukuda

芳雄福田

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Individual

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1983-12-13

Filing date

1983-12-13

Publication date

1985-07-05

1983-12-13 Application filed by Individual filed Critical Individual

1983-12-13 Priority to JP58235622A priority Critical patent/JPS60126252A/ja

1985-07-05 Publication of JPS60126252A publication Critical patent/JPS60126252A/ja

1988-01-21 Publication of JPS632949B2 publication Critical patent/JPS632949B2/ja

Status Granted legal-status Critical Current

Links

-1 aliphatic carboxylate salt Chemical class 0.000 title claims description 7
238000002360 preparation method Methods 0.000 title abstract description 10
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 18
150000007933 aliphatic carboxylic acids Chemical class 0.000 claims abstract description 5
210000003169 central nervous system Anatomy 0.000 claims abstract description 4
235000019441 ethanol Nutrition 0.000 claims description 8
238000004519 manufacturing process Methods 0.000 claims description 3
239000008194 pharmaceutical composition Substances 0.000 claims description 3
230000002401 inhibitory effect Effects 0.000 claims description 2
KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 abstract description 11
GFLPSABXBDCMCN-UHFFFAOYSA-N 4,4-diethoxybutan-1-amine Chemical compound CCOC(OCC)CCCN GFLPSABXBDCMCN-UHFFFAOYSA-N 0.000 abstract description 2
239000003814 drug Substances 0.000 abstract description 2
229940079593 drug Drugs 0.000 abstract description 2
150000001875 compounds Chemical class 0.000 abstract 2
230000000881 depressing effect Effects 0.000 abstract 1
239000000463 material Substances 0.000 abstract 1
150000003839 salts Chemical class 0.000 description 11
KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 10
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
238000000034 method Methods 0.000 description 9
VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 7
239000002253 acid Substances 0.000 description 7
238000000921 elemental analysis Methods 0.000 description 6
238000002844 melting Methods 0.000 description 6
230000008018 melting Effects 0.000 description 6
241000699670 Mus sp. Species 0.000 description 5
VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 5
150000001412 amines Chemical class 0.000 description 4
HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
238000001953 recrystallisation Methods 0.000 description 4
239000001384 succinic acid Substances 0.000 description 4
239000003795 chemical substances by application Substances 0.000 description 3
238000009472 formulation Methods 0.000 description 3
239000000203 mixture Substances 0.000 description 3
DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
230000007059 acute toxicity Effects 0.000 description 2
231100000403 acute toxicity Toxicity 0.000 description 2
239000007864 aqueous solution Substances 0.000 description 2
KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 2
239000012530 fluid Substances 0.000 description 2
239000001530 fumaric acid Substances 0.000 description 2
230000002496 gastric effect Effects 0.000 description 2
230000006742 locomotor activity Effects 0.000 description 2
235000019359 magnesium stearate Nutrition 0.000 description 2
230000007935 neutral effect Effects 0.000 description 2
HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 2
230000001988 toxicity Effects 0.000 description 2
231100000419 toxicity Toxicity 0.000 description 2
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
NUDWCJJMQATDKB-NPNYKPOCSA-N (1s,2s)-1-(3,4-dimethoxyphenyl)-2-[2-methoxy-4-[(e)-prop-1-enyl]phenoxy]propan-1-ol Chemical compound C1=C(OC)C(OC)=CC=C1[C@H](O)[C@H](C)OC1=CC=C(\C=C\C)C=C1OC NUDWCJJMQATDKB-NPNYKPOCSA-N 0.000 description 1
DHKHKXVYLBGOIT-UHFFFAOYSA-N 1,1-Diethoxyethane Chemical compound CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
QWCKQJZIFLGMSD-GSVOUGTGSA-N D-alpha-aminobutyric acid Chemical compound CC[C@@H](N)C(O)=O QWCKQJZIFLGMSD-GSVOUGTGSA-N 0.000 description 1
FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
241000699666 Mus <mouse, genus> Species 0.000 description 1
FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
239000007983 Tris buffer Substances 0.000 description 1
NUDWCJJMQATDKB-SZNDQCEHSA-N Virolin Natural products COc1ccc(cc1OC)[C@@H](O)[C@@H](C)Oc2ccc(C=CC)cc2OC NUDWCJJMQATDKB-SZNDQCEHSA-N 0.000 description 1
150000008043 acidic salts Chemical class 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
239000011230 binding agent Substances 0.000 description 1
210000004556 brain Anatomy 0.000 description 1
239000002775 capsule Substances 0.000 description 1
239000013078 crystal Substances 0.000 description 1
230000003247 decreasing effect Effects 0.000 description 1
238000010586 diagram Methods 0.000 description 1
125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
238000004821 distillation Methods 0.000 description 1
239000002552 dosage form Substances 0.000 description 1
230000000694 effects Effects 0.000 description 1
239000007888 film coating Substances 0.000 description 1
238000009501 film coating Methods 0.000 description 1
238000005984 hydrogenation reaction Methods 0.000 description 1
229920003063 hydroxymethyl cellulose Polymers 0.000 description 1
229940031574 hydroxymethyl cellulose Drugs 0.000 description 1
238000001727 in vivo Methods 0.000 description 1
239000000543 intermediate Substances 0.000 description 1
239000007928 intraperitoneal injection Substances 0.000 description 1
239000007788 liquid Substances 0.000 description 1
229940031703 low substituted hydroxypropyl cellulose Drugs 0.000 description 1
239000000314 lubricant Substances 0.000 description 1
229940049920 malate Drugs 0.000 description 1
238000005259 measurement Methods 0.000 description 1
230000004060 metabolic process Effects 0.000 description 1
235000005152 nicotinamide Nutrition 0.000 description 1
239000011570 nicotinamide Substances 0.000 description 1
WCFYXOLUODJLKB-UHFFFAOYSA-N odoratisol B Natural products C1=C(O)C(OC)=CC(C(O)C(C)OC=2C(=CC(C=CC)=CC=2)OC)=C1 WCFYXOLUODJLKB-UHFFFAOYSA-N 0.000 description 1
230000035515 penetration Effects 0.000 description 1
239000000546 pharmaceutical excipient Substances 0.000 description 1
230000000144 pharmacologic effect Effects 0.000 description 1
239000002243 precursor Substances 0.000 description 1
238000011403 purification operation Methods 0.000 description 1
238000007670 refining Methods 0.000 description 1
239000000377 silicon dioxide Substances 0.000 description 1
VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
239000000243 solution Substances 0.000 description 1
238000003756 stirring Methods 0.000 description 1
238000007920 subcutaneous administration Methods 0.000 description 1
239000007929 subcutaneous injection Substances 0.000 description 1
230000001629 suppression Effects 0.000 description 1
208000024891 symptom Diseases 0.000 description 1
239000008399 tap water Substances 0.000 description 1
235000020679 tap water Nutrition 0.000 description 1
239000011975 tartaric acid Substances 0.000 description 1
235000002906 tartaric acid Nutrition 0.000 description 1
230000002123 temporal effect Effects 0.000 description 1
230000004102 tricarboxylic acid cycle Effects 0.000 description 1
150000003628 tricarboxylic acids Chemical class 0.000 description 1
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1

Landscapes

Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

JP58235622A 1983-12-13 1983-12-13 ４・４’−ジエトオキシブチルアミンの脂肪族カルボン酸塩およびその製造方法 Granted JPS60126252A (ja)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
JP58235622A JPS60126252A (ja)	1983-12-13	1983-12-13	４・４’−ジエトオキシブチルアミンの脂肪族カルボン酸塩およびその製造方法

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP58235622A JPS60126252A (ja)	1983-12-13	1983-12-13	４・４’−ジエトオキシブチルアミンの脂肪族カルボン酸塩およびその製造方法

Publications (2)

Publication Number	Publication Date
JPS60126252A true JPS60126252A (ja)	1985-07-05
JPS632949B2 JPS632949B2 (da)	1988-01-21

Family

ID=16988734

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
JP58235622A Granted JPS60126252A (ja)	1983-12-13	1983-12-13	４・４’−ジエトオキシブチルアミンの脂肪族カルボン酸塩およびその製造方法

Country Status (1)

Country	Link
JP (1)	JPS60126252A (da)

1983
- 1983-12-13 JP JP58235622A patent/JPS60126252A/ja active Granted

Also Published As

Publication number	Publication date
JPS632949B2 (da)	1988-01-21

Publication	Publication Date	Title
DE3884563T2 (de)	1994-02-17	Aminomethyl-oxo-oxazolidinyl-ethenylbenzen-Derivate, nützlich als antibakterielles Mittel.
DE69425662T2 (de)	2001-04-12	Als heilmittel nutzbare piperazin verbindungen
DE69311130T2 (de)	1997-09-18	Arylpropionsäurederivat, verfahren zu seiner herstellung und seine verwendung als analgetikum
JPS6049192B2 (ja)	1985-10-31	新規置換ベンズアミド、その製造方法及びこれを有効成分とする向精神薬
JPH0692386B2 (ja)	1994-11-16	カルボン酸誘導体の新規二価金属塩
DE2011806C3 (de)	1981-12-03	Tricyclische Verbindungen, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zubereitungen
DE2851435A1 (de)	1979-06-13	Substituierte amid-derivate des l- und dl-phenylglycins, verfahren zu ihrer herstellung und diese derivate enthaltende arzneimittel
DE2059985C3 (de)	1979-10-04	Rechtsdrehende, basisch substituierte Phenylacetonitrile, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
JPH05500822A (ja)	1993-02-18	経口的に活性な非中毒性鎮痛薬
JPH0699307B2 (ja)	1994-12-07	抗痴呆剤
DE2941288A1 (de)	1980-04-30	Cystein-derivate
JPH06511231A (ja)	1994-12-15	２−（ピロリジニル−１−メチル）−ピペリジン誘導体およびκ受容体アゴニストとしてのその使用
DE4131584A1 (de)	1993-03-25	Imidazolylmethyl-pyridine, ihre herstellung und anwendung als pharmazeutika
DE1931240A1 (de)	1970-01-02	Aminoalkancarbonsaeuren
JPS60126252A (ja)	1985-07-05	４・４’−ジエトオキシブチルアミンの脂肪族カルボン酸塩およびその製造方法
DD205682A5 (de)	1984-01-04	Verfahren zur herstellung von (-)-2-(1-(2,6-dichlorphenoxy)-ethyl)-1,3-diazacyclopent-2-en und seinen salzen
DE69615845T2 (de)	2002-06-20	Polycyclische alkaloid-derivate als nmda-rezeptor-antagonisten
PT90802B (pt)	1994-11-30	Processo para a preparacao de derivados de propanolamina e de composicoes farmaceuticas que os contem
DE102005014080B4 (de)	2007-11-22	Additionssalze des Tolperison, Verfahren zu deren Herstellung, Verwendung derselben und diese enthaltende Arzneimittel
JPS60116678A (ja)	1985-06-24	ｎ‐プロパノールアミン誘導体エーテル
US3903165A (en)	1975-09-02	Ethynylaryl amines and processes for their preparation
JPH05503510A (ja)	1993-06-10	光学的に純粋な（ｓ）―アテノロールを含む組成物と方法
US3056792A (en)	1962-10-02	Unsymmetrical 1, 3-diamino-2-propanols
JPS60255781A (ja)	1985-12-17	ラクトン誘導体、その製法及びそれを含む医薬組成物
DE2919553A1 (de)	1979-11-22	Tetrahydroisochinolinderivat, verfahren zu seiner herstellung und es enthaltende arzneimittel